Literature DB >> 16248844

The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death.

Andrea C LeBlanc1.   

Abstract

Neuronal loss is associated with Alzheimer's disease (AD). However, it not clear what type of mechanisms underlie this neuronal loss and if neuronal loss is directly responsible for the progressive dementia of AD. This review summarizes the recent evidence for neuronal loss in AD relative to the level of cognitive impairment. It further describes the current evidence for an apoptotic mechanism in AD. Lastly, a summary of the evidence for synaptic loss being responsible for dementia rather than neuronal loss is presented. A novel hypothesis emerges from this data to explain all aspects of AD pathophysiology. This all inclusive hypothesis called the attrition hypothesis states that activation of the effector caspase-6 in AD due to one or a variety of insults is responsible for the breakdown of the cytoskeletal structure of neurites and damages proper trafficking of proteins and organelles thus resulting in the observed clinical and pathological features of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248844     DOI: 10.2174/156720505774330573

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  43 in total

1.  Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation.

Authors:  Dalia Halawani; Sylvain Tessier; Dominique Anzellotti; David A Bennett; Martin Latterich; Andréa C LeBlanc
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 2.  Biological roles of prion domains.

Authors:  Sergey G Inge-Vechtomov; Galina A Zhouravleva; Yury O Chernoff
Journal:  Prion       Date:  2007 Oct-Dec       Impact factor: 3.931

3.  Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Authors:  C Conejero-Goldberg; T M Hyde; S Chen; U Dreses-Werringloer; M M Herman; J E Kleinman; P Davies; T E Goldberg
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

Review 4.  Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases.

Authors:  Tetsumori Yamashima; Tsuguhito Ota; Eishiro Mizukoshi; Hiroyuki Nakamura; Yasuhiko Yamamoto; Mitsuru Kikuchi; Tatsuya Yamashita; Shuichi Kaneko
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 5.  MicroRNAs and deregulated gene expression networks in neurodegeneration.

Authors:  Kai-Christian Sonntag
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

6.  A caspase cascade regulating developmental axon degeneration.

Authors:  David J Simon; Robby M Weimer; Todd McLaughlin; Dara Kallop; Karen Stanger; Jing Yang; Dennis D M O'Leary; Rami N Hannoush; Marc Tessier-Lavigne
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

7.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

8.  Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor.

Authors:  Britney Williams; Donard S Dwyer
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

9.  Structural basis for executioner caspase recognition of P5 position in substrates.

Authors:  Guoxing Fu; Alexander A Chumanevich; Johnson Agniswamy; Bin Fang; Robert W Harrison; Irene T Weber
Journal:  Apoptosis       Date:  2008-11       Impact factor: 4.677

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.